Back

News

Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.

  1. News

News


Gaucher Disease Monitoring and Treatment Management

Cambridge, MA USA & Rostock, Germany, March 24, 2020 – CENTOGENE...


Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (Global Newswire) – CENTOGENE (Nasdaq: CNTG), a...


Cambridge, MA, USA and Rostock/Berlin, Germany, March 17, 2020 (Global Newswire) – CENTOGENE N.V. (Nasdaq: CNTG), a...


Cambridge, MA, USA and Rostock/Berlin, Germany, March 9, 2020 – CENTOGENE (Nasdaq: CNTG) ─ The Company today announced...


Mexico City, February 29, 2020 - More than 300 participants gathered on Saturday at Hotel Marriot Reforma in Mexico City...


Cambridge, MA, USA & Rostock/Berlin, Germany, February 29, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company...


On Saturday, February 29th, CENTOGENE, OMER, and ALIBER will celebrate International Rare Disease Day with an event for...


Cambridge, MA, USA & Rostock, Germany – February 25, 2020 – CENTOGENE (Nasdaq: CNTG), a commercial-stage company...


State-of-the-art Biorepository in Rostock, Germany is the first CAP-accredited repository outside the U.S.

Cambridge,...


Supporting Patients for Accelerated Diagnosis and Treatment Development

Cambridge, MA USA & Rostock, Germany December...